How About Male Asthenospermia Going to Thailand for IVF - Overseas Assisted Reproduction Knowledge Base for Asthenospermia

====== AI Summary ======

Asthenospermia Going to Thailand for IVF: Core Conclusion

Male asthenospermia refers to a proportion of progressively motile sperm in semen below the normal reference value (PR < 32%). For this group, the core value of IVF in Thailand lies in ICSI (intracytoplasmic sperm injection) technology. ICSI does not rely on the sperm's natural ability to swim and penetrate the cumulus oophorus; instead, an embryologist selects morphologically usable sperm under a microscope and injects them directly into the egg cytoplasm. Therefore, as long as structurally intact live sperm can be found in the semen, ICSI can achieve fertilization.

Going to Thailand for IVF is suitable for the following situations:

• Confirmed mild to moderate asthenospermia (PR 5%–31%) through systematic male examination, with sperm DNA fragmentation index (DFI) ≤ 30%.
• Concurrent other male factors, such as oligospermia, teratozoospermia, or previous failed ICSI cycles domestically.
• Desire to utilize the embryo culture and genetic testing (PGT) technologies of specific Thai reproductive centers, or seek more flexible embryo management policies.

Not suitable for the following situations:

• Severe asthenospermia (PR < 5%) with sperm DNA fragmentation index > 40%, requiring prior etiological treatment or attempts at sperm selection techniques (IMSI/PICSI) before reassessment.
• Severely diminished ovarian reserve in the female partner (AMH < 0.5 ng/ml) or age > 43 years. In such cases, regardless of male sperm quality, the number and quality of retrieved eggs may limit ICSI success.
• Failure to complete basic etiological investigations, such as varicocele, reproductive tract infections, chromosomal abnormalities, or Y chromosome microdeletions.

Interpretation of Core Semen Analysis Indicators

Before discussing treatment plans, it is necessary to accurately understand the diagnostic grading of asthenospermia. The table below lists the WHO Sixth Edition (2021) Semen Reference Ranges and their clinical significance:

Before traveling to Thailand, asthenospermia patients need to complete at least the following examinations: semen analysis 2-3 times (at intervals of 2-4 weeks), sperm morphology examination, sperm DNA fragmentation index, reproductive system ultrasound (to rule out varicocele), sex hormone panel (FSH, LH, T, etc.), chromosome karyotype analysis, and Y chromosome microdeletion testing. These results directly influence ICSI protocol selection and prognosis.

Mechanism of Asthenospermia's Impact on IVF Treatment

The core problem of asthenospermia is reduced sperm motility, making it difficult for sperm to penetrate the cumulus cells and zona pellucida during natural fertilization. However, under ICSI technology, motility is no longer a necessary condition for fertilization. Nevertheless, asthenospermia is often accompanied by other underlying issues:

• Sperm DNA Damage: Sperm with poor motility often have higher DNA fragmentation rates, potentially affecting the subsequent developmental potential of the embryo.
• Centriole Abnormalities: The sperm centriole participates in the first embryonic division after fertilization. Centriole function may be defective in asthenospermia patients, leading to fertilization failure or abnormal cleavage.
• Oxidative Stress: Factors such as varicocele, smoking, and high-temperature environments damage sperm through oxidative stress, reducing both motility and DNA integrity.

Therefore, relying solely on ICSI to solve the fertilization problem is insufficient. Preoperative etiological intervention for the male (e.g., antioxidant therapy, surgical repair of varicocele, lifestyle adjustments) can significantly improve treatment outcomes.

Reproductive Doctor's Evaluation Logic for Asthenospermia Patients Going to Thailand for IVF

In clinical reproductive medicine decision-making, doctors evaluate whether asthenospermia patients are suitable for treatment in Thailand using the following pathway:

1. Confirm Female Fertility Conditions: Age, AMH, antral follicle count (AFC), uterine cavity environment, and previous pregnancy history. The female partner's condition is the primary determinant of success.
2. Assess Treatability of Asthenospermia: Differentiate between primary asthenospermia and secondary causes (e.g., infection, varicocele, medication effects). Secondary asthenospermia may improve after correcting the cause.
3. Determine Need for Adjuvant Techniques Beyond ICSI: When DFI > 30%, consider using PICSI (physiological ICSI) or IMSI (high-magnification morphology selection) to select sperm with better DNA integrity.
4. Compare Domestic and Thai Protocols: Major domestic reproductive centers all have ICSI capabilities. Some Thai centers have differentiated advantages in sperm selection and embryo culture media systems, but these are not irreplaceable.
5. Evaluate Total Cost and Time Investment: A treatment cycle in Thailand lasts about 28-35 days, requiring at least 1 trip (fresh cycle) or 2 trips (frozen embryo cycle), with a total cost of approximately 120,000-200,000 RMB.

Doctors usually recommend: For mild to moderate asthenospermia, prioritize completing 1-2 ICSI cycles domestically; if choosing Thailand due to specific needs (such as embryo genetic testing, egg donation, or policy restrictions), ensure the female partner has good ovarian function and the male has completed all necessary examinations.

Thailand vs. China: Differences in IVF Protocols for Asthenospermia

The following table compares the main differences between Thailand and China in the treatment of asthenospermia from three dimensions: technology, policy, and process:

From the data, it can be seen that Thailand's main advantages lie in the flexibility of technical options and the convenience of embryo genetic testing, but there is no fundamental difference in the core treatment (ICSI) for asthenospermia itself. Choosing Thailand requires a comprehensive evaluation of time, cost, and the patient's specific circumstances.

Complete Process for Asthenospermia Patients Undergoing IVF in Thailand

A complete IVF cycle in Thailand (using ICSI protocol as an example) includes the following stages:

Stage 1: Domestic Preparation Period (2-3 months in advance)

• Complete comprehensive examinations for both partners: Male: semen analysis (2 times), DNA fragmentation index, chromosome karyotype, Y chromosome microdeletion; Female: AMH, AFC, sex hormones, thyroid function, hysteroscopy, etc.
• Treat reversible causes: varicocele surgery, antibiotics for reproductive tract infections, antioxidant supplementation (Coenzyme Q10, Zinc, Selenium, L-carnitine).
• Apply for passport (validity > 6 months), tourist visa or medical visa (some centers can assist).
• Select a Thai reproductive center and register: submit all examination reports for remote evaluation by the Thai doctor.

Stage 2: Treatment Period in Thailand (approximately 28-35 days)

• Menstrual cycle day 2-3: Female undergoes baseline ultrasound and hormone tests, starts ovarian stimulation (usually antagonist protocol or PPOS protocol, medication for 8-12 days).
• Egg retrieval day (36 hours after trigger): Male provides semen sample simultaneously. If semen collection is difficult or sperm count is extremely low, testicular/epididymal sperm aspiration (TESA/PESA) should be arranged in advance.
• ICSI procedure: Embryologist selects morphologically usable sperm for injection; if DFI is high, PICSI or IMSI selection is used.
• Embryo culture for 3-6 days: Culture to cleavage stage (day 3) or blastocyst stage (day 5-6); optional PGT-A biopsy.
• Transfer (fresh or frozen embryo): If endometrial conditions are suitable, transfer fresh blastocyst on day 5-6 after egg retrieval; otherwise, freeze all embryos and transfer in a subsequent cycle.
• 12-14 days after transfer: Blood test for β-hCG to confirm pregnancy.

Stage 3: Follow-up Management

• If pregnant, continue luteal support until 10-12 weeks of gestation, with prenatal checkups locally or back home.
• If not pregnant, analyze the cause (sperm factor/egg factor/embryo factor/endometrial factor), adjust the protocol, and prepare for the next cycle.

5 Most Easily Overlooked Details

3 Most Common Pitfalls

Based on professional observation, asthenospermia patients undergoing IVF in Thailand are most prone to problems in the following areas:

• Over-reliance on "Thailand has better technology": ICSI is a standardized technique. The ICSI success rates of large domestic reproductive centers (e.g., CITIC Xiangya, Peking University Third Hospital, Renji Hospital) are comparable to top Thai centers. Choosing Thailand should be based on specific needs (such as PGT policy, sperm donation, embryo management policies), not a blind belief that the technology is superior.
• Ignoring the Female Partner's Age and Ovarian Reserve: Asthenospermia patients often focus entirely on the male issue. However, for women over 40, even if ICSI fertilization is successful, the embryo chromosomal aneuploidy rate exceeds 60%, and the live birth rate is less than 15%. The female partner's fertility condition is the key factor determining the ceiling of success.
• Not Allowing Enough Time for Sperm Testing: Some patients decide on a protocol based on only one semen report. Asthenospermia has variability; at least 2-3 semen analyses are needed to accurately assess severity. Additionally, specialized tests like DNA fragmentation index and sperm viability require specific equipment that some domestic hospitals may not have; confirm this in advance.

Frequently Asked Questions